(Q30886208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

title

A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

José Portugal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

author name string

Silvia Villamarín

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

Sylvia Mansilla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

Waldemar Priebe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

volume

270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

page(s)

764-770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12581216%20AND%20SRC:MED&resulttype=core&format=json

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

18 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Structure-based design of a new bisintercalating anthracycline antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Analysis of the effects of daunorubicin and WP631 on transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Radiation sensitivity and apoptosis in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Parsing the free energy of anthracycline antibiotic binding to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Exploiting anthracycline scaffold for designing DNA-targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Induction of G2/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

p53 status and the efficacy of cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X

Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2003.03442.X